CIPO Patents = 1

EPO Patents = 4

Forward Citations = 28

Loading Chart...

4 inventors (with patents filed for the assignee):

Frank Baas (6 out of 6 patents)

Marc A Van Dijk (3 out of 42 patents)

Kees Fluiter (2 out of 2 patents)

4. Valeria Ramaglia (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12194091 - Antibodies that bind human C6 and uses thereof (2025-01-14),

2. 11590222 - Antibodies that bind human C6 and uses thereof (2023-02-28),

3. 10675348 - Antibodies that bind human C6 and uses thereof (2020-06-09),

4. 9089555 - Complement antagonists and uses thereof (2015-07-28),

5. 8703730 - Complement antagonists and uses thereof (2014-04-22),

6. 8703136 - Complement inhibition for improved nerve regeneration (2014-04-22),

Regenesance B.v. is a leading biotechnology company dedicated to developing innovative therapies for regenerative medicine. With a focus on stem cell research and tissue engineering, we aim to revolutionize the healthcare industry and improve patients' lives. Our team of experts is committed to advancing the field of regenerative medicine through cutting-edge research and development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#97 in Amsterdam

#971 in Netherlands

Amsterdam, Netherlands

Regenesance B.v.

Forward Citations = 28

4 inventors:

Frank Baas (6 out of 6 patents)

Marc A Van Dijk (3 out of 42 patents)

Kees Fluiter (2 out of 2 patents)

4. Valeria Ramaglia (1 out of 1 patent)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]

4 patents (EPO):

Please report any incorrect information to [email protected]